NLRP3-MODULATOREN

European patent · EP3753938 · Deleted

Register entry

Publication number
EP3753938
Application number
EP20169634
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 16, 2018
Published
Dec 23, 2020
Granted
Mar 20, 2024
Deleted
Sep 23, 2025
Reason
Annual fee unpaid
IPC classes
C07D 471/04 (2006.01)
A61P 35/00 (2006.01)
A61P 37/00 (2006.01)
A61K 31/437 (2006.01)
Priority
US 201762460677 P 17.02.2017
US 201762490881 P 27.04.2017
US 201762573991 P 18.10.2017
Divided from
EP18707612
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 23, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.09.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.09.2025

  2. Jan 29, 2025

    Change

    Published in Swissreg on 29.01.2025

  3. Mar 20, 2024

    Granted

    Published in Swissreg on 20.03.2024

Parties

Holder

Innate Tumor Immunity, Inc.

Route 206 and Province Line Road, Princeton, New Jersey 08543, US

Inventor

ROUSH, William R.

Tequesta, FL 33469, US

GHOSH, Shomir

Brookine, MA 02446, US

O'MALLEY, Daniel

Princeton, NJ 08543, US

OLHAVA, Edward James

Newton, MA 02460, US

GLICK, Gary

Ann Arbor, MI 48103, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.